GGrantIndex
← Leaderboards

William A Cliby

Mayo Clinic Coll Of Medicine, Rochester

$3,264,657
Attributed
$3,436,750
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $384.5K · FY200925
$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,436,750 · 6

By mechanism

P50$1,591,580 · 4
R01$1,404,692 · 1
K22$440,478 · 1

Top collaborators

Most similar at Mayo Clinic Coll Of Medicine, Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Research Personnel

Research focus

Research PersonnelOvarianBaseProgramsFundingMalignant Neoplasm Of OvaryWomanMinorityAwardTranslational ResearchFosteringClinicDisabled PersonsPublicationsClinical ResearchAnticancer ResearchDirect CostsCommunitiesCollaborationsCreativenessInnovationClinically RelevantClinical TrialsCancer Patient

Grant awards (23)

Development Research Program$142,283
P50 · FY2025 · CA · contact PI
Development Research Program$136,664
P50 · FY2024 · CA · contact PI
Development Research Program$150,153
P50 · FY2023 · CA · contact PI
Development Research Program$147,546
P50 · FY2022 · CA · contact PI
Development Research Program$147,870
P50 · FY2021 · CA · contact PI
Developmental Reserach Pilot Projects$133,604
P50 · FY2019 · CA · contact PI
Developmental Reserach Pilot Projects$99,600
P50 · FY2018 · CA · contact PI
Developmental Reserach Pilot Projects$99,606
P50 · FY2017 · CA · contact PI
Developmental Reserach Pilot Projects$95,166
P50 · FY2016 · CA · contact PI
Developmental Reserach Pilot Projects$94,902
P50 · FY2015 · CA · contact PI
Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer$307,889
R01 · FY2014 · CA · contact PI
Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer$298,367
R01 · FY2013 · CA · contact PI
Career Development Program$74,332
P50 · FY2013 · CA
Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer$317,411
R01 · FY2012 · CA · contact PI
Career Development Program$67,134
P50 · FY2012 · CA
Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer$317,411
R01 · FY2011 · CA · contact PI
Career Development Program$65,176
P50 · FY2011 · CA
Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer$163,614
R01 · FY2010 · CA · contact PI
Career Development Program$68,733
P50 · FY2010 · CA
Career Development Program$68,811
P50 · FY2009 · CA
ATR in Human Cancer and Anticancer Therapy$146,826
K22 · FY2004 · CA
ATR in Human Cancer and Anticancer Therapy$146,826
K22 · FY2003 · CA
ATR in Human Cancer and Anticancer Therapy$146,826
K22 · FY2002 · CA